Dzmitry Dzemidovich Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific (NYSE:BSX), CONMED (NYSE:CNMD), ResMed…
Read More »Dzmitry Dzemidovich Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific (NYSE:BSX), CONMED (NYSE:CNMD), ResMed…
Read More »